Finance
S&P 500 7,695.52 +28.92 +0.38% Dow 53,319.65 +257.70 +0.49% Nasdaq 26,399.10 +181.27 +0.69% NYSE Composite 24,615.49 +119.94 +0.49% Russell 2000 2,963.63 +10.46 +0.35% VIX 15.08 -0.12 -0.79%

NVO · Novo-Nordisk A/S

OMX NORDIC EXCHANGE COPENHAGEN A/S - Real Time Price • USD

Novo Nordisk A/S (NVO)

OMX NORDIC EXCHANGE COPENHAGEN A/S Pharmaceuticals
Options chain →
$47.07 +0.31 (+0.67%)
● Market open
DAY'S RANGE $47.07
$46.87 $47.97
52-WEEK RANGE $47.07
$224.25 $409.95

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$1,302.81B
P/E (TTM1)11.40
EPS2 (TTM)$26.18
Div Yield1.00%
Beta31.93
Volume60,337
Open47.97
Prev Close46.76
Bid / Ask47.05 / 47.06
Next Earnings 2026-11-04

Analyst Recommendations

Strong buy 5 Buy 6 Hold 22 Sell 2 Strong sell 1

Aggregate ratings for 2026-09-01 (36 analysts polled by Finnhub) — consensus count.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
NVO -7.26%
vs S&P 500 -18.97%
1-YEAR RETURN
NVO -15.93%
vs S&P 500 -34.91%
6-MONTH RETURN
NVO +23.80%
3-MONTH RETURN
NVO +10.98%

Valuation Measures & Ratios

Enterprise Value4$1,423.28B
Forward P/E514.36
PEG Ratio616.16
Price / Sales (TTM1)4.03
Price / Book74.82
EV4 / Revenue4.32
EV4 / EBITDA8.41
Profit Margin35.35%
Operating Margin43.13%
Return on Equity (ROE8)59.09%
Return on Assets (ROA9)21.08%
Avg Volume (3M)4,964,710
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short33,828,864
Change from Prior Settlement+14.97%
% of Float—
Days to Cover (Short Ratio)2.18

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

No accessible free API for these — links go to the source directly.

Morningstar Motley Fool MarketBeat

Financials

Financial statement data not available for this company — SEC EDGAR XBRL coverage only includes US GAAP 10-K/10-Q filers.

Institutional holders

SEC Form 13F filers holding NVO as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

No Form 4 insider transactions reported for this symbol.

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-09-03 14:13 UTC

Recent SEC filings are not available for this symbol right now.

Headlines about NVO (Novo-Nordisk A/S). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist